We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fosamax Users Urge High Court To Turn Down Merck Appeal

Law360 (June 6, 2018, 7:02 PM EDT) -- Fosamax users on Tuesday urged the U.S. Supreme Court not to hear Merck’s appeal of a Third Circuit decision reviving multidistrict litigation over the pharmaceutical giant's alleged failure to warn about its osteoporosis drug, saying that the case doesn’t meet the court’s usual standard for review.

Even though the U.S. solicitor general recently recommended that the high court hear the appeal, he too recognizes that it presents no circuit conflict, the patients said. The two sides are vying over why the U.S. Food and Drug Administration...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Merck Sharp & Dohme Corp., Petitioner v. Doris Albrecht, et al.


Case Number

17-290

Court

Supreme Court

Nature of Suit

4365 Personal Injury-Product Liability

Date Filed

August 24, 2017

Law Firms

Companies

Government Agencies

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.